Biopsy of pheochromocytomas and paragangliomas: Potential for disaster

Kimberly A. Vanderveen, Scott M. Thompson, Matthew R Callstrom, William Francis Young, Clive S. Grant, David R. Farley, Melanie L. Richards, Geoffrey B. Thompson

Research output: Contribution to journalArticle

68 Citations (Scopus)

Abstract

Background: Pheochromocytomas and paragangliomas are highly vascular neuroendocrine neoplasms that often secrete catecholamines. Percutaneous biopsy has been associated with life-threatening hemorrhage, hypertensive crisis, capsular disruption with tumor implantation, and death. We sought to determine the outcomes of biopsy in 20 consecutive patients. Methods: We reviewed retrospectively the medical records of patients with biopsied pheochromocytomas and paragangliomas referred to our Endocrine Division for subsequent management between 1995 and 2005. Biopsy complications, operative findings, and outcomes were reviewed. Results: Twenty patients (14 pheochromocytomas and 6 paragangliomas) were biopsied percutaneously prior to referral. Mean tumor diameter was 6.4 cm (range, 1-15). Pre-biopsy biochemical testing was not performed in 90% of patients, and was negative in the remainder. Fourteen patients (70%) developed a biopsy-related complication, including: increased difficulty of the definitive operation in 7 of 17 (41%) operative cases with 1 patient requiring conversion to an open procedure; severe hypertension (15%); hematoma (30%); incorrect or inadequate biopsy (25%); severe pain (25%); and delay in surgical treatment (15%). Mean follow-up was 58 months, with 4 tumor-related deaths and 2 recurrences. Conclusion: Biochemical testing prior to biopsy of adrenal or suspicious retroperitoneal masses is critical to exclude a catecholamine-secreting neoplasm because serious complications and increased operative difficulty can result.

Original languageEnglish (US)
Pages (from-to)1158-1166
Number of pages9
JournalSurgery
Volume146
Issue number6
DOIs
StatePublished - Dec 2009
Externally publishedYes

Fingerprint

Paraganglioma
Pheochromocytoma
Disasters
Biopsy
Catecholamines
Neoplasms
Vascular Neoplasms
Conversion to Open Surgery
Hematoma
Medical Records
Referral and Consultation
Hemorrhage
Hypertension
Recurrence
Pain

ASJC Scopus subject areas

  • Surgery

Cite this

Vanderveen, K. A., Thompson, S. M., Callstrom, M. R., Young, W. F., Grant, C. S., Farley, D. R., ... Thompson, G. B. (2009). Biopsy of pheochromocytomas and paragangliomas: Potential for disaster. Surgery, 146(6), 1158-1166. https://doi.org/10.1016/j.surg.2009.09.013

Biopsy of pheochromocytomas and paragangliomas : Potential for disaster. / Vanderveen, Kimberly A.; Thompson, Scott M.; Callstrom, Matthew R; Young, William Francis; Grant, Clive S.; Farley, David R.; Richards, Melanie L.; Thompson, Geoffrey B.

In: Surgery, Vol. 146, No. 6, 12.2009, p. 1158-1166.

Research output: Contribution to journalArticle

Vanderveen, KA, Thompson, SM, Callstrom, MR, Young, WF, Grant, CS, Farley, DR, Richards, ML & Thompson, GB 2009, 'Biopsy of pheochromocytomas and paragangliomas: Potential for disaster', Surgery, vol. 146, no. 6, pp. 1158-1166. https://doi.org/10.1016/j.surg.2009.09.013
Vanderveen, Kimberly A. ; Thompson, Scott M. ; Callstrom, Matthew R ; Young, William Francis ; Grant, Clive S. ; Farley, David R. ; Richards, Melanie L. ; Thompson, Geoffrey B. / Biopsy of pheochromocytomas and paragangliomas : Potential for disaster. In: Surgery. 2009 ; Vol. 146, No. 6. pp. 1158-1166.
@article{61817f1ae2f24f35a46ef31ca1d72577,
title = "Biopsy of pheochromocytomas and paragangliomas: Potential for disaster",
abstract = "Background: Pheochromocytomas and paragangliomas are highly vascular neuroendocrine neoplasms that often secrete catecholamines. Percutaneous biopsy has been associated with life-threatening hemorrhage, hypertensive crisis, capsular disruption with tumor implantation, and death. We sought to determine the outcomes of biopsy in 20 consecutive patients. Methods: We reviewed retrospectively the medical records of patients with biopsied pheochromocytomas and paragangliomas referred to our Endocrine Division for subsequent management between 1995 and 2005. Biopsy complications, operative findings, and outcomes were reviewed. Results: Twenty patients (14 pheochromocytomas and 6 paragangliomas) were biopsied percutaneously prior to referral. Mean tumor diameter was 6.4 cm (range, 1-15). Pre-biopsy biochemical testing was not performed in 90{\%} of patients, and was negative in the remainder. Fourteen patients (70{\%}) developed a biopsy-related complication, including: increased difficulty of the definitive operation in 7 of 17 (41{\%}) operative cases with 1 patient requiring conversion to an open procedure; severe hypertension (15{\%}); hematoma (30{\%}); incorrect or inadequate biopsy (25{\%}); severe pain (25{\%}); and delay in surgical treatment (15{\%}). Mean follow-up was 58 months, with 4 tumor-related deaths and 2 recurrences. Conclusion: Biochemical testing prior to biopsy of adrenal or suspicious retroperitoneal masses is critical to exclude a catecholamine-secreting neoplasm because serious complications and increased operative difficulty can result.",
author = "Vanderveen, {Kimberly A.} and Thompson, {Scott M.} and Callstrom, {Matthew R} and Young, {William Francis} and Grant, {Clive S.} and Farley, {David R.} and Richards, {Melanie L.} and Thompson, {Geoffrey B.}",
year = "2009",
month = "12",
doi = "10.1016/j.surg.2009.09.013",
language = "English (US)",
volume = "146",
pages = "1158--1166",
journal = "Surgery (United States)",
issn = "0039-6060",
publisher = "Mosby Inc.",
number = "6",

}

TY - JOUR

T1 - Biopsy of pheochromocytomas and paragangliomas

T2 - Potential for disaster

AU - Vanderveen, Kimberly A.

AU - Thompson, Scott M.

AU - Callstrom, Matthew R

AU - Young, William Francis

AU - Grant, Clive S.

AU - Farley, David R.

AU - Richards, Melanie L.

AU - Thompson, Geoffrey B.

PY - 2009/12

Y1 - 2009/12

N2 - Background: Pheochromocytomas and paragangliomas are highly vascular neuroendocrine neoplasms that often secrete catecholamines. Percutaneous biopsy has been associated with life-threatening hemorrhage, hypertensive crisis, capsular disruption with tumor implantation, and death. We sought to determine the outcomes of biopsy in 20 consecutive patients. Methods: We reviewed retrospectively the medical records of patients with biopsied pheochromocytomas and paragangliomas referred to our Endocrine Division for subsequent management between 1995 and 2005. Biopsy complications, operative findings, and outcomes were reviewed. Results: Twenty patients (14 pheochromocytomas and 6 paragangliomas) were biopsied percutaneously prior to referral. Mean tumor diameter was 6.4 cm (range, 1-15). Pre-biopsy biochemical testing was not performed in 90% of patients, and was negative in the remainder. Fourteen patients (70%) developed a biopsy-related complication, including: increased difficulty of the definitive operation in 7 of 17 (41%) operative cases with 1 patient requiring conversion to an open procedure; severe hypertension (15%); hematoma (30%); incorrect or inadequate biopsy (25%); severe pain (25%); and delay in surgical treatment (15%). Mean follow-up was 58 months, with 4 tumor-related deaths and 2 recurrences. Conclusion: Biochemical testing prior to biopsy of adrenal or suspicious retroperitoneal masses is critical to exclude a catecholamine-secreting neoplasm because serious complications and increased operative difficulty can result.

AB - Background: Pheochromocytomas and paragangliomas are highly vascular neuroendocrine neoplasms that often secrete catecholamines. Percutaneous biopsy has been associated with life-threatening hemorrhage, hypertensive crisis, capsular disruption with tumor implantation, and death. We sought to determine the outcomes of biopsy in 20 consecutive patients. Methods: We reviewed retrospectively the medical records of patients with biopsied pheochromocytomas and paragangliomas referred to our Endocrine Division for subsequent management between 1995 and 2005. Biopsy complications, operative findings, and outcomes were reviewed. Results: Twenty patients (14 pheochromocytomas and 6 paragangliomas) were biopsied percutaneously prior to referral. Mean tumor diameter was 6.4 cm (range, 1-15). Pre-biopsy biochemical testing was not performed in 90% of patients, and was negative in the remainder. Fourteen patients (70%) developed a biopsy-related complication, including: increased difficulty of the definitive operation in 7 of 17 (41%) operative cases with 1 patient requiring conversion to an open procedure; severe hypertension (15%); hematoma (30%); incorrect or inadequate biopsy (25%); severe pain (25%); and delay in surgical treatment (15%). Mean follow-up was 58 months, with 4 tumor-related deaths and 2 recurrences. Conclusion: Biochemical testing prior to biopsy of adrenal or suspicious retroperitoneal masses is critical to exclude a catecholamine-secreting neoplasm because serious complications and increased operative difficulty can result.

UR - http://www.scopus.com/inward/record.url?scp=70549103321&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70549103321&partnerID=8YFLogxK

U2 - 10.1016/j.surg.2009.09.013

DO - 10.1016/j.surg.2009.09.013

M3 - Article

C2 - 19958944

AN - SCOPUS:70549103321

VL - 146

SP - 1158

EP - 1166

JO - Surgery (United States)

JF - Surgery (United States)

SN - 0039-6060

IS - 6

ER -